Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.30 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | LCK | P06239 | 1/20 | 0.30 |
| ▸ | SRC | P12931 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21264773 | 0.91 | MAPK1 (0.34) | MAPK1HTTALDH1A1TSHRADORA2B | |
| SCHEMBL17150243 | 0.91 | MAPK1 (0.39) | MAPK1HTTALDH1A1TSHRADORA2B | |
| SCHEMBL18701288 | 0.91 | MAPK1 (0.39) | MAPK1HTTALDH1A1TSHRADORA2B | |
| SCHEMBL17150262 | 0.89 | MAPK1 (0.38) | MAPK1HTTALDH1A1TSHRADORA2B | |
| SCHEMBL17150268 | 0.89 | MAPK1 (0.38) | MAPK1HTTALDH1A1TSHRADORA2B | |
| SCHEMBL17150259 | 0.89 | MAPK1 (0.38) | MAPK1HTTALDH1A1TSHRADORA2B | |
| SCHEMBL21264465 | 0.89 | MAPK1 (0.35) | MAPK1HTTALDH1A1TSHRADORA2B | |
| SCHEMBL21264776 | 0.89 | ALDH1A1 (0.38) | MAPK1HTTALDH1A1TSHRADORA2B | |
| SCHEMBL21264771 | 0.87 | PIK3CA (0.31) | MAPK1HTT | |
| SCHEMBL20929428 | 0.87 | MAPK1 (0.35) | MAPK1HTTALDH1A1TSHRADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190252623-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2019-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190252623-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | ZYX, NSD3, NES | MAPK1 2007/4885HTT 4100/4885ALDH1A1 3144/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.